2021
Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?
Zheng Y, Cai M, Li E, Fang W, Shen C, Zhang Y. Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity? Frontiers In Immunology 2021, 12: 671425. PMID: 34220818, PMCID: PMC8249196, DOI: 10.3389/fimmu.2021.671425.Peer-Reviewed Original ResearchConceptsMyelin oligodendrocyte glycoproteinMultiple sclerosisMyelin oligodendrocyte glycoprotein-antibody testingClinical phenotypeConus medullaris involvementUnder-recognized entityProportion of patientsSteroid-dependentMedullary involvementOligodendrocyte glycoproteinMOGADRadiological manifestationsRecurrent episodesTherapeutic responseDisease courseAntibody seropositivityUnder-recognizedPatientsAntibody testMyelitisSclerosisSeropositivityMyelinManifestationsPhenotype
2020
Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome
Zheng Y, Shen C, Wang S, Yang F, Cai M, Fang W, Zhang Y, Ding M. Application of the 2017 McDonald criteria in a Chinese population with clinically isolated syndrome. Therapeutic Advances In Neurological Disorders 2020, 13: 1756286419898083. PMID: 32010225, PMCID: PMC6971959, DOI: 10.1177/1756286419898083.Peer-Reviewed Original ResearchClinically isolated syndromeChinese patientsDiagnostic performanceAccurate diagnosis of multiple sclerosisMultiple sclerosisDiagnosis of multiple sclerosisFollow-up dataDetection of MSRetrospective studyMcDonald criteriaAccurate diagnosisTertiary hospitalChinese populationInterquartile rangeLow specificitySurvival analysisDiagnostic criteriaPatientsAsian populationsSyndromeClinicSclerosisBaselineInterquartile